GLP-1, or glucagon-like peptide-1, is a hormone produced in the gut
The most relevant clinical data comes from Pendulum Glucose Control product (a related five-strain formulation), which demonstrated modest improvements in A1C and postprandial glucose in a small proof-of-concept trial with 76 type 2 diabetes patients
Our product range covers the most sought-after research compounds in 2026: BPC-157 for tissue repair and gut health studies, Semaglutide and Retatrutide for weight loss and metabolic research, Ipamorelin and CJC-1295 for growth hormone secretion studies, TB-500 for recovery research, and GHK-Cu for skin elasticity and collagen production studies
doi:10.1073/pnas.1522014113 16
The skyrocketing demand for GLP-1 weight-loss medications has led to a surge in compounding pharmacies producing similar products at lower prices, but researchers warn that these medications are not always as safe as they claim
Mild side effects may occur frequently with dose increases but become less noticeable over time 5
